Skip navigation

Navigate the Evolving Healthcare Landscape • Demonstrate Specialty Product Value • Optimize Access and Adoption

August 15-16, 2018
  • Philadelphia, PA

Hundreds of leaders in Access, Reimbursement and Commercial Operations have benefited from CBI’s Reimbursement and Access summit. Now in its 6th year, this highly-acclaimed event arms attendees with best practices and practical strategies during a time of unprecedented uncertainty on complex issues. Benefit from in-depth sessions covering the evolving healthcare and political landscape, specialty drug pricing, value frameworks, coupons and co-pays, formulary exclusion and much more!

CLE & CPE
Credits
Available! Pending Approval

Interactive Panels, Compelling Sessions and Expert Insights on the Most Pressing Issues:

  • Marketplace changes impacting specialty drug management
  • 340B’s growing role in reimbursement and access and future policy
  • Innovative opportunities to focus on the value of specialty products
  • Global trends influencing payer decision-making and market access
  • Specialty drug utilization management and cost containment
  • Approaches and attributes for value proposition enhancement
  • Hub and SPP models to streamline processes and support access

Benefit From Two Tracks of Tailored Content:

I PAYER STRATEGIES
AND REIMBURSEMENT
II ACCESS AND
AFFORDABILITY

PREVIOUS ATTENDEE
ACCLAIM:

Reimbursement and Access 2018

Navigate the Evolving Healthcare Landscape • Demonstrate Specialty Product Value • Optimize Access and Adoption

Hundreds of leaders in Access, Reimbursement and Commercial Operations have benefited from CBI’s Reimbursement and Access summit. Now in its 6th year, this highly-acclaimed event arms attendees with best practices and practical strategies during a time of unprecedented uncertainty on complex issues. Benefit from in-depth sessions covering the evolving healthcare and political landscape, specialty drug pricing, value frameworks, coupons and co-pays, formulary exclusion and much more!

CLE & CPE
Credits
Available! Pending Approval

Interactive Panels, Compelling Sessions and Expert Insights on the Most Pressing Issues:

  • Marketplace changes impacting specialty drug management
  • 340B’s growing role in reimbursement and access and future policy
  • Innovative opportunities to focus on the value of specialty products
  • Global trends influencing payer decision-making and market access
  • Specialty drug utilization management and cost containment
  • Approaches and attributes for value proposition enhancement
  • Hub and SPP models to streamline processes and support access

Benefit From Two Tracks of Tailored Content:

I PAYER STRATEGIES
AND REIMBURSEMENT
II ACCESS AND
AFFORDABILITY

PREVIOUS ATTENDEE
ACCLAIM: